최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Phytomedicine : international journal of phytotherapy and phytopharmacology, v.13 no.9/10, 2006년, pp.643 - 650
Long, S.R. (Oregon State University College of Pharmacy, Corvallis, OR, USA) , Carey, R.A. (Oregon State University College of Pharmacy, Corvallis, OR, USA) , Crofoot, K.M. (Oregon State University College of Pharmacy, Corvallis, OR, USA) , Proteau, P.J. (Oregon State University College of Pharmacy, Corvallis, OR, USA) , Filtz, T.M. (Corresponding author. Tel.: +15417375802)
AbstractExtracts of hawthorn (Crataegus oxycantha) have become popular herbal supplements for their well-recognized cardiotonic effects. Many commercial preparations have been used successfully in the treatment of congestive heart failure, although the active principles within these extracts have ye...
Planta Med. Ammon 43 209 1981 10.1055/s-2007-971502 Crataegus, toxicology and pharmacology. Part II: Pharmacodynamics (author's translation of title)
Life Sci. Chen 63 1983 1998 10.1016/S0024-3205(98)00476-7 Endothelium-dependent relaxation induced by hawthorn extract in rat mesenteric artery
HerbalGram Hobbs 22 19 1990 Hawthorn: a literature review
Arzneimittelforschung Joseph 45 1261 1995 Pharmacologic action profile of Crataegus extract in comparison to epinephrine, amirinone, milrinone and digoxin in the isolated perfused guinea pig heart (author's translation of title)
Life Sci. Kim 67 121 2000 10.1016/S0024-3205(00)00608-1 Procyanidins in Crataegus extract evoke endothelium-dependent vasorelaxation in rat aorta
Fortschr. Med. Leuchtgens 111 352 1993 Crataegus Special Extract WS 1442 in NYHA II heart failure. A placebo controlled randomized double-blind study (author's translation of title)
Planta Med. Muller 65 335 1999 10.1055/s-1999-13997 Crataegus extract blocks potassium currents in guinea pig ventricular cardiac myocytes
Am. J. Chin. Med. Petkov 7 197 1979 10.1142/S0192415X79000180 Plants with hypotensive, antiatheromatous and coronarodilatating action
Am. J. Med. Pittler 114 665 2003 10.1016/S0002-9343(03)00131-1 Hawthorn extract for treating chronic heart failure: meta-analysis of randomized trials
Exp. Cell Res. Polinger 63 78 1970 10.1016/0014-4827(70)90333-2 Separation of cell types in embryonic heart cell cultures
Arzneimittelforschung Popping 45 1157 1995 Effect of a hawthorn extract on contraction and energy turnover of isolated rat cardiomyocytes
Am. J. Health Syst. Pharm. Rigelsky 59 417 2002 10.1093/ajhp/59.5.417 Hawthorn: pharmacology and therapeutic uses
Arzneimittelforschung Schussler 45 842 1995 Myocardial effects of flavonoids from Crataegus species
J. Cardiovasc. Pharmacol. Schwinger 35 700 2000 10.1097/00005344-200005000-00004 Crataegus special extract WS 1442 increases force of contraction in human myocardium cAMP-independently
Herz Tauchert 24 465 1999 10.1007/BF03044432 High-dose Crataegus extract WS 1442 in the treatment of NYHA stage II heart failure
Toxicology Toraason 56 107 1989 10.1016/0300-483X(89)90216-3 Comparative toxicity of allylamine and acrolein in cultured myocytes and fibroblasts from neonatal rat heart
Planta Med. Wagner 45 98 1982 10.1055/s-2007-971254 Cardioactive drugs IV. Cardiotonic amines from Crataegus oxyacantha (author's translation of title)
Phytother. Res. Walker 16 48 2002 10.1002/ptr.947 Promising hypotensive effect of hawthorn extract: a randomized double-blind pilot study of mild, essential hypertension
Am. J. Physiol. Wang 276 H167 1999 Metallothionein-overexpressing neonatal mouse cardiomyocytes are resistant to H2O2 toxicity
Phytomedicine Zapfe jun 8 262 2001 10.1078/0944-7113-00041 Clinical efficacy of Crataegus extract WS 1442 in congestive heart failure NYHA class II
※ AI-Helper는 부적절한 답변을 할 수 있습니다.